Should the physician feel strongly that a patient is indeed displaying the sign of Leser-Trelat, screening for an underlying neoplasm would be indicated. Obtaining a thorough history, review or systems, and physical examination may help direct the workup of the patient towards a certain malignancy. Laboratory evaluation including a complete blood count (CBC) and complete metabolic panel (CMP) should be obtained along with gender-specific cancer screenings such as mammography, Pap smears, and prostate serum antigen (PSA) testing. Imaging such as a chest x-ray is recommended along with both upper and lower endoscopies given that the sign of Leser-Trelat is most commonly associated malignancy is a gastrointestinal adenocarcinoma.